StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Morphic Therapeutic (MORF) PT Raised to $60 at Jefferies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
People depended on Moderna (NASDAQ:MRNA) in 2020 and 2021 for COVID-19 vaccines, but the pharma market landscape has changed dramatically since then. Now, Moderna has to demonstrate that it can evolve. Yet, the company’s latest quarterly report offers hope to frustrated shareholders. All in all, I am bullish on MRNA stock and envision a major turnaround story for 2024. Moderna is a well-known drug and vaccine manufacturer. The company doesn’t only develop COVID-19 vaccines, of course. In actuali